16 juni, 2017

Immunovia reveals today the new logotype, one that can continue to grow and adapt with the development of the IMMray™ technology and its clinical applications in cancers and autoimmune diseases. This brand identity change is important for Immunovia for three reasons: -The company name is now easy to read and understand -New IMMray™ based tests […]

3 februari, 2017

Nature Reviews Cancer magazine published today online, ahead of print an article focused on Precision Diagnostics. This Opinion article, written by Professor Carl Borrebaeck, describes the trends and progress being made in identifying protein biomarker signatures of clinical utility in cancer using, in particular, blood-based proteomics. Click to read article. Pdf for download Title: Precision […]

4 november, 2016

Every day, more than 900 people around the world die from pancreatic cancer. Only 6 percent of the patients diagnosed with pancreatic cancer survive 5 years. According to a recent global survey, more than 60 percent of people know “almost nothing” about pancreatic cancer. To create awareness about pancreatic cancer, patient support organizations, industry, healthcare providers and politicians join […]

Pancreatic cancers are one of the most deadly cancers. The cancers are often diagnosed late, making them one of the most hard-to-treat cancers. To create awareness on the aggressive diseases and stir a political discussion for better care, the Medicon Village based company Immunovia is taking the lead on organizing an event at Medicon Village. […]

15 juni, 2016

The International Symposium on Pancreatic Cancer, “Pancreas 2016”, that took place in Glasgow UK last week, brought together 350 medical oncologists, surgeons, radiographers, gastroenterologists, molecular pathologists, pathologists and clinical and basic scientists from all over the globe, to explore current knowledge in the diagnosis and treatment of pancreatic cancer. Prof. Carl Borrebaeck, Lund University, Sweden, […]